Ernst Geutjes

Ernst Geutjes currently serves as the Interim Chief Business Officer at Flindr Therapeutics, where responsibilities include facilitating a strategic pivot and raising a $20 million Series A. In addition, Ernst acts as an advisor for Cumulus Oncology, a director at VC Life Foundation, and the Vice President of Business Development at Genase Therapeutics. Ernst is also the founder of Oncopreneur, providing support in oncology venture creation and operational assistance to various biotech companies. Previous roles include Partner at Aglaia Oncology Funds, where involvement encompassed venture capital investment analysis and interim-CEO responsibilities, as well as board observer positions at Inthera Bioscience and Macrophage Pharma. Educational credentials include an MSc in Biomedical Sciences from the University of Amsterdam and Harvard University, alongside additional training at Harvard Medical School and the University of California, Berkeley.